inhibitor

(redirected from MAO inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to MAO inhibitor: Ritalin, SSRI, serotonin, COMT inhibitor, MAOI inhibitor
See: deterrent
References in periodicals archive ?
(2004) described as MAO inhibitors intoxication could perhaps be classified as a case of serotonin syndrome, which may include mental status changes, agitation, tremor, diarrhea, autonomic instability, hyperthermia, sweating, muscle spasms, rhabdomyolysis, and possible death (Boyer & Shannon 2005; Hilton et al.
The biochemical changes after CCK-4 immunization as well as behavioral changes are opposite to those resulting form MAO inhibitor immunization.
Although interactions between MAO-A inhibitors and tyramine-rich foods are uncommon, patients receiving MAO inhibitors should be aware of this potentially dangerous drug--food interaction(62)(63) (Tables 1 and 2).
aid, but for the treatment of depression in conjunction with MAO inhibitors. But in the U.S., it was never developed as a legitimate drug.
"MAO inhibitors are embossed in people's brains as being horrendously tricky and dangerous," he said.
At a meeting, the FDA's Psychopharmacologic Drugs Advisory Committee voted 7-4 that the available data supported the "reasonable safety" of the 20-mg formulation of a transdermal patch containing the irreversible MAO inhibitor selegiline without a recommendation to restrict aged cheeses and other tyramine-rich foods in the diet.
In 2005, 0.1% of antidepressant prescriptions were for an MAO inhibitor, according to data from IMS, a market research company.
At a meeting in late October, the FDA's Psychopharmacologic Drugs Advisory Committee voted 7-4 that the available data supported the "reasonable safety" of the 20-mg formulation of a transdermal patch containing the irreversible MAO inhibitor selegiline without a recommendation to restrict aged cheeses and other tyramine-rich foods in the diet.
Although the MAO inhibitor selegiline is selective at low doses for MAO-B receptors, given in oral doses that achieve an antidepressant effect it loses its selectivity, inhibiting both MAO-A and MAO-B and arousing the same safety issues as with other MAO inhibitors.
The most treatment-refractory patients may respond to a tricyclic, possibly in combination with an SSRI, or to an MAO inhibitor.
Selegiline is an MAO inhibitor prescribed, in its oral formulation, for Parkinson's disease.
Investigators assessed the MAO inhibitor phenelzine in randomized controlled trials and open trials, but it is not suggested as a first- or second-line choice, she said.